DopamineMesencephalonDopaminergic NeuronsNeuronsTyrosine 3-MonooxygenaseSubstantia NigraVentral Tegmental AreaCorpus StriatumOxidopamineParkinson DiseaseMPTP PoisoningDopamine AgentsReceptors, Dopamine D2Dopamine Plasma Membrane Transport ProteinsReceptors, Dopamine3,4-Dihydroxyphenylacetic AcidDopamine Agonists1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineDopamine AntagonistsParkinsonian DisordersLevodopaNeurons, Afferent1-Methyl-4-phenylpyridiniumRats, Sprague-DawleyAntiparkinson AgentsNuclear Receptor Subfamily 4, Group A, Member 2Motor Neuronsalpha-SynucleinBasal GangliaParkinson Disease, SecondaryBrainMice, Inbred C57BLNerve DegenerationSynaptic TransmissionDopamine Uptake InhibitorsRats, WistarNerve Tissue ProteinsCells, CulturedReceptors, NicotinicDose-Response Relationship, DrugAction PotentialsImmunohistochemistryRotenoneReceptors, Dopamine D1Neuroprotective AgentsNeostriatumgamma-Aminobutyric AcidAdrenergic AgentsBehavior, AnimalVesicular Monoamine Transport ProteinsApomorphineNeurotoxinsGlial Cell Line-Derived Neurotrophic FactorGABAergic NeuronsParaquatDisease Models, AnimalPatch-Clamp TechniquesCell DeathSulpirideTegmentum MesencephaliCell CountDiencephalonAnimals, NewbornQuinpiroleElectrophysiologyDendritesAxonsMicrogliaMice, KnockoutElectric StimulationTime FactorsMice, TransgenicSynapsesHomovanillic AcidSynucleinsCholinergic NeuronsBenzazepinesNeural InhibitionNerve Growth FactorsLewy BodiesHaloperidolCell DifferentiationHippocampusSerotoninMotor ActivityCerebral CortexMembrane PotentialsAnalysis of VarianceCell SurvivalBrain Tissue TransplantationHerbicidesReceptors, Dopamine D32,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepinePresynaptic TerminalsNeurogenesisSignal TransductionModels, NeurologicalAnimals, Genetically ModifiedGlutamic AcidNeuroglia